» Authors » Carlos Jerjes-Sanchez

Carlos Jerjes-Sanchez

Explore the profile of Carlos Jerjes-Sanchez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 552
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Camm C, Virdone S, Jerjes-Sanchez C, Oh S, Eikelboom J, Oto A, et al.
Int J Cardiol . 2024 Dec; 421():132866. PMID: 39631531
Objective: To determine whether stroke prevention strategy, comorbidity management, and clinical outcome risks differ across atrial fibrillation (AF) care specialties. Methods: Newly diagnosed non-valvular AF patients enrolled in the international,...
2.
Salinas-Casanova J, Jimenez-Franco V, Jerjes-Sanchez C, Quintanilla-Gutierrez J, De la Pena-Almaguer E, Eguiluz-Hernandez D, et al.
Catheter Cardiovasc Interv . 2024 Nov; 105(2):308-320. PMID: 39543018
Background: Quantitative flow ratio (QFR) analysis is a simple and non-invasive coronary physiological assessment method with evidence for evaluating stable coronary artery disease with correlation to fractional flow reserve (FFR)....
3.
Gutierrez-Gallegos P, Jimenez-Franco V, Jerjes-Sanchez C, Quevedo-Salazar R, Rodriguez-Rivera J, Paredes-Gutierrez E, et al.
Front Cardiovasc Med . 2024 Aug; 11:1444636. PMID: 39105076
Despite the elevated mortality rates associated with high-risk pulmonary embolism (PE), this condition remains understudied. Data regarding the effectiveness and safety of invasive therapies such as venoarterial extracorporeal membrane oxygenation...
4.
Jerjes-Sanchez C, Ramirez-Rivera A, Hernandez N, Cueto Robledo G, Garcia-Aguilar H, Gutierrez-Fajardo P, et al.
Pulm Circ . 2024 Jun; 14(2):e12395. PMID: 38887742
Data on demographic characteristics and therapeutic approaches in Latin American pulmonary arterial hypertension (PAH) patients are scarce. Pulmonary Hypertension Mexican registry (REMEHIP) is a multicenter Mexican registry of adult and...
5.
Jerjes-Sanchez C, Porres-Aguilar M
Front Med (Lausanne) . 2023 Dec; 10:1281073. PMID: 38089875
No abstract available.
6.
Castro-Varela A, Garza Salas A, Barrios-Ruiz A, Ambriz Morales E, Abascal-Lanzagorta P, Reyes-Chavez M, et al.
Vaccine X . 2023 Dec; 15:100407. PMID: 38075434
Methods: According to the PRISMA statement, we conducted a systematic review and meta-analysis, and the protocol was registered in PROSPERO. The main objective is to identify differences among survivors and...
7.
Paredes-Vazquez J, Rubio-Infante N, Lopez-de la Garza H, Brunck M, Guajardo-Lozano J, Ramos M, et al.
Virol J . 2023 Sep; 20(1):203. PMID: 37661270
Background: Inflammation affecting the heart and surrounding tissues is a clinical condition recently reported following COVID-19 mRNA vaccination. Assessing trends of these events related to immunization will improve vaccine safety...
8.
Porres-Aguilar M, Rosovsky R, Jimenez D, Mukherjee D, Rivera-Lebron B, Kaatz S, et al.
J Thromb Haemost . 2023 Apr; 21(5):1390-1392. PMID: 37121622
No abstract available.
9.
Castro-Varela A, Martinez-Magallanes D, Reyes-Chavez M, Gonzalez-Rayas J, Paredes-Vazquez J, Vazquez-Garza E, et al.
Angiology . 2023 Apr; 75(7):625-634. PMID: 37005343
Data on characteristics and outcomes of coronavirus (COVID)-19 patients complicated with arterial thrombosis (AT) are scarce. Therefore, we carried out a systematic review (PRISMA, PROSPERO statements; PubMed, Scopus, and Web...
10.
Haas S, Farjat A, Pieper K, Ageno W, Angchaisuksiri P, Bounameaux H, et al.
TH Open . 2022 Dec; 6(4):e354-e364. PMID: 36452204
 Direct oral anticoagulants (DOACs) provide a safe, effective alternative to vitamin K antagonists (VKAs) for venous thromboembolism (VTE) treatment, as shown via intention-to-treat comparative effectiveness analysis. However, on-treatment analysis is...